APA

Iida M., Bahrar H., Brand T. M., Pearson H. E., Coan J. P., Orbuch R. A., Flanigan B. G., Swick A. D., Prabakaran P. J., Lantto J., Horak I. D., Kragh M., Salgia R., Kimple R. J. & Wheeler D. L. (20170629). Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab. : Molecular cancer therapeutics.

Chicago

Iida Mari, Bahrar Harsh, Brand Toni M, Pearson Hannah E, Coan John P, Orbuch Rachel A, Flanigan Bailey G, Swick Adam D, Prabakaran Prashanth J, Lantto Johan, Horak Ivan D, Kragh Michael, Salgia Ravi, Kimple Randy J and Wheeler Deric L. 20170629. Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab. : Molecular cancer therapeutics.

Harvard

Iida M., Bahrar H., Brand T. M., Pearson H. E., Coan J. P., Orbuch R. A., Flanigan B. G., Swick A. D., Prabakaran P. J., Lantto J., Horak I. D., Kragh M., Salgia R., Kimple R. J. and Wheeler D. L. (20170629). Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab. : Molecular cancer therapeutics.

MLA

Iida Mari, Bahrar Harsh, Brand Toni M, Pearson Hannah E, Coan John P, Orbuch Rachel A, Flanigan Bailey G, Swick Adam D, Prabakaran Prashanth J, Lantto Johan, Horak Ivan D, Kragh Michael, Salgia Ravi, Kimple Randy J and Wheeler Deric L. Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab. : Molecular cancer therapeutics. 20170629.